Literature DB >> 2832025

Recurrent pleomorphic salivary adenoma--the relevance of age at first presentation.

A D McGregor1, M Burgoyne, K C Tan.   

Abstract

All cases of pleomorphic salivary adenoma treated at the West of Scotland Regional Plastic and Oral Surgery Unit, Canniesburn Hospital, over the 10-year period 1974-1983 have been reviewed. Nearly one-fifth of patients were treated for recurrence. These patients presented with their primary tumour at a significantly younger age (p less than 0.001) than those who remained disease-free. Sixteen of 31 who subsequently developed recurrence were under 30 years of age at initial presentation. Of all patients under 30 years of age at first presentation, 42% subsequently developed recurrent diseases.

Entities:  

Mesh:

Year:  1988        PMID: 2832025     DOI: 10.1016/0007-1226(88)90048-3

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  11 in total

1.  Pleomorphic adenoma (benign mixed tumour) of the minor salivary glands of the upper lip.

Authors:  Subhas Chandra Debnath; A K Adhyapok
Journal:  J Maxillofac Oral Surg       Date:  2010-09-22

2.  Bone Formation in Pleomorphic Adenoma: A Case Report.

Authors:  Eb Robson Gubod; Anand Ramanathan; Sherrie Chong Mei Yee; Wanninayake M Tilakaratne
Journal:  Cureus       Date:  2022-03-05

3.  Clinicopathologic Characteristics and Prognostic Factors of Primary and Recurrent Pleomorphic Adenoma: A Single Institution Retrospective Study of 705 Cases.

Authors:  Bayan Alzumaili; Bin Xu; Maelle Saliba; Abderhman Abuhashem; Ian Ganly; Ronald Ghossein; Nora Katabi
Journal:  Am J Surg Pathol       Date:  2021-11-15       Impact factor: 6.298

4.  Neither expression of VEGF-C/D nor lymph vessel density supports lymphatic invasion as the mechanism responsible for local spread of recurrent salivary pleomorphic adenoma.

Authors:  R Salzman; I Stárek; L Kučerová; A Skálová; J Hoza
Journal:  Virchows Arch       Date:  2014-01       Impact factor: 4.064

5.  Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence.

Authors:  T Hamada; S Matsukita; M Goto; S Kitajima; S K Batra; T Irimura; K Sueyoshi; K Sugihara; S Yonezawa
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

6.  Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings.

Authors:  Tatsuya Yamamoto; Hirohiko Kimura; Kuniyoshi Hayashi; Yoshiaki Imamura; Masaki Mori
Journal:  Neuroradiology       Date:  2018-07-02       Impact factor: 2.804

7.  Imaging characteristics of recurrent pleomorphic adenoma of the parotid gland.

Authors:  G Moonis; P Patel; Y Koshkareva; J Newman; L A Loevner
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

8.  Pleomorphic Adenoma Originating from Heterotopic Salivary Tissue of the Upper Neck: A Diagnostic Pitfall.

Authors:  Riccardo La Macchia; Salvatore Stefanelli; Vincent Lenoir; Nicolas Dulguerov; Jean-Claude Pache; Minerva Becker
Journal:  Case Rep Otolaryngol       Date:  2017-11-15

Review 9.  Why Do Parotid Pleomorphic Adenomas Recur? A Systematic Review of Pathological and Surgical Variables.

Authors:  Pavel Dulguerov; Jelena Todic; Marc Pusztaszeri; Naif H Alotaibi
Journal:  Front Surg       Date:  2017-05-15

10.  Clinical manifestations of recurrent parotid pleomorphic adenoma.

Authors:  Myung-Whan Suh; J Hun Hah; Seong Keun Kwon; Young-Ho Jung; Tack-Kyun Kwon; Kwang Hyun Kim; Myung-Whun Sung
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-12-31       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.